Journal article · 2011 · Open access

Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery

Arup K. Ghose, Torsten Herbertz, Robert L. Hudkins, Bruce D. Dorsey, John P. Mallamo

ACS Chemical Neuroscience, 3(1), 50–68 · Published 2 November 2011 · DOI 10.1021/cn200100h

Read the free full textCite this paper

In brief

“Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery” is a 2011 journal article by Arup K. Ghose and 4 co-authors, published in ACS Chemical Neuroscience. OpenAlex counts 468 citations as of 15 November 2026, which puts it in the top 1% of works published in 2011 by citations. It is open access: the full text is free to read at ACS Chemical Neuroscience.

Citations
468
Most cited in
2019 (47)
Field-weighted impact
6.64
References
48
Authors
5

Abstract

The central nervous system (CNS) is the major area that is affected by aging. Alzheimer's disease (AD), Parkinson's disease (PD), brain cancer, and stroke are the CNS diseases that will cost trillions of dollars for their treatment. Achievement of appropriate blood-brain barrier (BBB) penetration is often considered a significant hurdle in the CNS drug discovery process. On the other hand, BBB penetration may be a liability for many of the non-CNS drug targets, and a clear understanding of the physicochemical and structural differences between CNS and non-CNS drugs may assist both research areas. Because of the numerous and challenging issues in CNS drug discovery and the low success rates, pharmaceutical companies are beginning to deprioritize their drug discovery efforts in the CNS arena. Prompted by these challenges and to aid in the design of high-quality, efficacious CNS compounds, we analyzed the physicochemical property and the chemical structural profiles of 317 CNS and 626 non-CNS oral drugs. The conclusions derived provide an ideal property profile for lead selection and the property modification strategy during the lead optimization process. A list of substructural units that may be useful for CNS drug design was also provided here. A classification tree was also developed to differentiate between CNS drugs and non-CNS oral drugs. The combined analysis provided the following guidelines for designing high-quality CNS drugs: (i) topological molecular polar surface area of <76 Å(2) (25-60 Å(2)), (ii) at least one (one or two, including one aliphatic amine) nitrogen, (iii) fewer than seven (two to four) linear chains outside of rings, (iv) fewer than three (zero or one) polar hydrogen atoms, (v) volume of 740-970 Å(3), (vi) solvent accessible surface area of 460-580 Å(2), and (vii) positive QikProp parameter CNS. The ranges within parentheses may be used during lead optimization. One violation to this proposed profile may be acceptable. The chemoinformatics approaches for graphically analyzing multiple properties efficiently are presented.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Ghose, A. K., Herbertz, T., Hudkins, R. L., Dorsey, B. D., & Mallamo, J. P. (2011). Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery. ACS Chemical Neuroscience, 3(1), 50–68. https://doi.org/10.1021/cn200100h

MLA 9

Ghose, Arup K., et al. “Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery.” ACS Chemical Neuroscience, vol. 3, no. 1, 2011, pp. 50–68. https://doi.org/10.1021/cn200100h.

Chicago

Ghose, Arup K., Torsten Herbertz, Robert L. Hudkins, Bruce D. Dorsey, and John P. Mallamo. 2011. “Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery.” ACS Chemical Neuroscience 3 (1): 50–68. https://doi.org/10.1021/cn200100h.

Harvard

Ghose, A. K. et al. (2011) ‘Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery’, ACS Chemical Neuroscience, 3(1), pp. 50–68. doi:10.1021/cn200100h.

IEEE

A. K. Ghose, T. Herbertz, R. L. Hudkins, B. D. Dorsey, and J. P. Mallamo, “Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery,” ACS Chemical Neuroscience, vol. 3, no. 1, pp. 50–68, 2011, doi: 10.1021/cn200100h.

BibTeX

@article{ghose2011knowledge,
  title     = {{Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery}},
  author    = {Ghose, Arup K. and Herbertz, Torsten and Hudkins, Robert L. and Dorsey, Bruce D. and Mallamo, John P.},
  journal   = {ACS Chemical Neuroscience},
  year      = {2011},
  volume    = {3},
  number    = {1},
  pages     = {50--68},
  doi       = {10.1021/cn200100h},
  url       = {https://doi.org/10.1021/cn200100h}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20172525
20184242
20194747
20202727
20213535
20224040
20233333
20244242
20254040
20263636

Its field-weighted citation impact is 6.64: it has been cited 6.64 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • CNS drug discovery
  • blood-brain barrier penetration
  • lead selection
  • lead optimization
  • physicochemical properties
  • structure-property relationships
  • classification trees
  • polar surface area

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Ghose, A. K., Herbertz, T., Hudkins, R. L., Dorsey, B. D., & Mallamo, J. P. (2011). Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery. ACS Chemical Neuroscience, 3(1), 50–68. https://doi.org/10.1021/cn200100h

How many times has this paper been cited?

468 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at ACS Chemical Neuroscience.

Who wrote this paper?

Arup K. Ghose, Torsten Herbertz, Robert L. Hudkins, Bruce D. Dorsey, John P. Mallamo.

What is the DOI of this paper?

10.1021/cn200100h. The permanent link is https://doi.org/10.1021/cn200100h.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.